K123891

Substantially Equivalent

SPARTAN RX CYP2C19 TEST SYSTEM

Applicant: Spartan Bioscience, Inc.
Product code: NTI
Advisory panel: Clinical Toxicology
Date received: 2012-12-18
Decision date: 2013-08-12
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Redwood Shores, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.